Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    neurology AND university AND San Francisco | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Brain Development Research Program
Conditions: Brain Disorders;   Aicardi Syndrome
Intervention:
2 Recruiting A TSEC for Symptom Management in Menopausal Women With Multiple Sclerosis
Conditions: Menopause;   Multiple Sclerosis
Interventions: Drug: Tissue Selective Estrogen Complex;   Drug: Placebo
3 Not yet recruiting High-dose Erythropoietin for Asphyxia and Encephalopathy
Conditions: Neonatal Encephalopathy;   Birth Asphyxia
Interventions: Drug: Normal saline placebo;   Drug: erythropoietin
4 Recruiting Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
Conditions: Dementia;   Traumatic Brain Injury (TBI);   Mild Cognitive Impairment (MCI);   Chronic Traumatic Encephalopathy (CTE);   Post-traumatic Stress Disorder (PTSD)
Intervention:
5 Recruiting A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
Condition: AADC Deficiency
Intervention: Drug: AAV2-hAADC
6 Recruiting Efficacy of Web-Based Social-Cognitive Interventions in Right Hemisphere Stroke and Frontotemporal Dementia
Conditions: Frontotemporal Dementia;   Right Sided Cerebral Hemisphere Cerebrovascular Accident
Intervention: Other: Brain HQ
7 Recruiting Vitamin D Supplementation in Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: Vitamin D3
8 Recruiting Established Status Epilepticus Treatment Trial
Condition: Benzodiazepine Refractory Status Epilepticus
Interventions: Drug: Fosphenytoin;   Drug: Levetiracetam;   Drug: Valproic acid
9 Recruiting Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
Condition: Familial Frontotemporal Dementia
Intervention:
10 Recruiting Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
Condition: Pediatric Multiple Sclerosis
Intervention:
11 Not yet recruiting Therapy in Amyotrophic Lateral Sclerosis With Memantine at 20 mg BID (TAME)
Conditions: Amyotrophic Lateral Sclerosis;   Frontal Temporal Dementia
Interventions: Drug: Memantine;   Drug: Placebo (for Memantine)
12 Recruiting Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations
Condition: Cryptogenic Sensory Polyneuropathy
Interventions: Drug: Nortriptyline;   Drug: Duloxetine;   Drug: Pregabalin;   Drug: Mexiletine
13 Recruiting The Human Epilepsy Project
Condition: Focal Epilepsy
Intervention:
14 Recruiting Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Telmisartan
15 Recruiting Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease (AD)
Intervention:
16 Recruiting Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Conditions: Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Progressive Muscular Atrophy;   Multisystem Proteinopathy
Intervention:
17 Recruiting A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome
Conditions: Dravet Syndrome;   Seizure Disorder
Interventions: Drug: ZX008 (Fenfluramine Hydrochloride);   Drug: Matching Placebo
18 Not yet recruiting Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)
Condition: Multiple Sclerosis
Interventions: Drug: MD1003 100mg capsule;   Drug: PLACEBO
19 Recruiting Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Device: Deep Brain Stimulation
20 Recruiting Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Condition: Huntington's Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.